Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

440 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

NCT04025879

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Local Institution - 0104 Tampa, Florida, United States
  • Local Institution - 0040 Atlanta, Georgia, United States
  • Local Institution - 0120 Augusta, Georgia, United States
  • Local Institution - 0145 Chicago, Illinois, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer

NCT04931654

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • Research Site Atlanta, Georgia, United States
  • Research Site Fort Wayne, Indiana, United States
  • Research Site New York, United States
  • Research Site Nashville, Tennessee, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment

NCT05241834

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Medicine-Comprehensive Cancer Center Chicago, Illinois, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

NCT03212404

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +67 more
Locations
  • Research Site Wollongong, New South Wales, Australia
  • Research Site Benowa, Queensland, Australia
  • Research Site Buderim, Queensland, Australia
  • Research Site Greenslopes, Queensland, Australia
View all 48 locations
View Trial Details
Active, Not Recruiting

Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)

NCT04597671

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • ZGT Almelo, Netherlands
  • AmsterdamUMC - location VUmc Amsterdam, Netherlands
  • Radiotherapie Groep Arnhem, Netherlands
  • Rijnstate Arnhem, Netherlands
View all 14 locations
View Trial Details

Related conditions